100% Original L-Malic Acid - GnRH Antagonist Used for Peptides Synthesis – Gentolex
100% Original L-Malic Acid - GnRH Antagonist Used for Peptides Synthesis – Gentolex Detail:
Product Detail
|
NO |
Products |
CAS No. |
Application |
Key Quality Indicator |
||||
|
Purity |
Isomer |
Specific impurity |
*Max1 |
Moisture |
||||
|
1 |
Fmoc-3-(2-naphthyl)-D-Ala-OH |
138774-94-4 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
2 |
Ac-3-(2-naphthyl)-D-Ala-OH |
37440-01-0 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
3 |
Fmoc-3-(3-pyridinyl)-D-Ala-OH |
142994-45-4 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
4 |
Fmoc-4-chloro-D-Phe-OH |
142994-19-2 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
5 |
Fmoc-D-Cit-OH |
200344-33-8 |
Cetrorelix |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
6 |
Fmoc-D-Ala-OH.H2O |
79990-15-1 |
Most products |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤6.5% |
|
7 |
Fmoc-D-Aph(tBuCbm)-OH |
1433975-21-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
8 |
Fmoc-D-Aph(Cbm)-OH |
324017-22-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
9 |
Fmoc-L-Aph(L-Hor)-OH |
1253282-31-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
10 |
Fmoc-L-Lys(iPr,Boc)-OH |
201003-48-7 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
11 |
Fmoc-N-Me-Tyr(tBu)-OH |
133373-24-7 |
Abarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
12 |
Fmoc-D-Asn(Trt)-OH |
180570-71-2 |
Abarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
13 |
Fmoc-HomoArg(Et)2-OH.HCl |
1864003-26-8 |
Ganirelix |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
14 |
Fmoc-D-HomoArg(Et)2-OH.HCl |
2098497-24-4 |
Ganirelix |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
15 |
Fmoc-Lys(nicotinoyl)-OH |
252049-11-9 |
Antide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
16 |
Fmoc-D-Lys(nicotinoyl)-OH |
252049-12-0 |
Antide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
* Max1 = Max Unknown Impurity
Other Indicator:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
TOC and Conductivity
TOC and conductivity of main supply and return points are monitored periodically. TOC is monitored by QC on every week. Conductivity is monitored online and recorded by purified water station operator once every four hours. The conductivity is monitored at the primary RO, secondary RO, EDI and total return point of distribution system. The specification of purified water is in place and conforms to pre-defined specification which no more than 1.3 µs/cm at 25°C (USP). For main supply and return points, full test. is performed every week, for other using point in the circulating loop, full test is performed once every month. The full test includes characters, pH, nitrate, nitrite, ammonia, conductivity, TOC, non-volatile substances, heavy metals, microbial limits and bacterial endotoxin.
Product detail pictures:
Related Product Guide:
With responsible good quality method, good status and excellent client services, the series of solutions produced by our company are exported to lots of countries and regions for 100% Original L-Malic Acid - GnRH Antagonist Used for Peptides Synthesis – Gentolex , The product will supply to all over the world, such as: Switzerland, California, Austria, We have now a large share in global market. Our company has strong economic strength and offers excellent sale service. Now we have established faith, friendly, harmonious business relationship with customers in different countries. , such as Indonesia, Myanmar, Indi and other Southeast Asian countries and European, African and Latin American countries.
By Amy from Mali - 2017.08.18 18:38
Problems can be quickly and effectively resolved, it is worth to be trust and working together.
By Fanny from Czech Republic - 2018.10.01 14:14
